The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
A phase II study of pazopanib (GW786034) in patients with stage IV non-small cell lung cancer that have failed at least two prior chemotherapy regimens.
Sachdev P. Thomas
No relevant relationships to disclose
Timmy-Tai A Ho
No relevant relationships to disclose
Kathryn L Jackson
No relevant relationships to disclose
Pankaj Kumar
No relevant relationships to disclose
Patrick Leigh Gomez
No relevant relationships to disclose
Jamie Harper
No relevant relationships to disclose
Nancy Williams
No relevant relationships to disclose
Morgan N Medus
No relevant relationships to disclose
James Lloyd Wade
No relevant relationships to disclose